RE: FDA news16 Nov 2021 08:24
that FDA PR is somehwat good news for Mologic, as it should push them a bit further towards the front of the queue. However post gates/soros purchase and transformation into a social enterprise, we have no idea if Mologic/GAD see the US as a priority market for them, and what impact that has on their response times to any FDA requests for further info.
Also as Capt has pointed out, as the months and months go by, odx is getting further behind the curve, odx awaits US prof use approval, when the world wants self-test use, and most of the tests in the last 2 months getting FDA EUA approval are self-test products. And given that ODX has independently sought self-test approval in the EU, does that suggest that independent of Mologic, ODX will have to seeking self-test approval themselves in the USA for home use.